EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep Sequencing and Phenotyping in an Australian Tuberous Sclerosis Complex “No Mutations Identified” Cohort

Clara W T Chung iD, Adam M Bournazos, Lok Chi Denise Chan, Vanessa Sarkozy, John Lawson, Sean E Kennedy, Sandra T Cooper, Edwin P Kirk, David Mowat

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.70017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Clara W T Chung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Genetics, Sydney Children's Hospital, Randwick, New South Wales, Australia. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Phenotype, Tuberous Sclerosis Complex 2 Protein, Tuberous Sclerosis Complex 1 Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberous sclerosis complex (TSC) is a variable multisystem disorder. The “no mutations identified” (NMI) group are reportedly phenotypically milder than those with an identified molecular cause, and often have mosaic or intronic variants not detected by standard sequencing methods.

Methods

We describe the phenotypes in an Australian TSC NMI group ( n = 18) and a molecular testing strategy implementable in a diagnostic laboratory. Massively parallel sequencing (MPS) of the whole genomic regions of TSC1 and TSC2 was performed using DNA extracted from multiple tissue samples per participant.

Results

Our study showed that the phenotype in TSC NMI individuals can be similar to those with heterozygous, particularly TSC1 , variants. Although neurodevelopmental outcomes can be less severe, the number of organ systems involved was similar to the non‐mosaic groups. A diagnostic yield of 72% (13/18) was achieved, with the majority (10/13) being mosaic variants and the remainder heterozygous variants missed on previous testing.

Conclusion

Testing DNA from multiple tissue samples allowed for validation of otherwise discarded low‐level mosaic variants and detection of mosaic variants by MPS without excessive cost or the need for specialised techniques. Implementing this approach in a diagnostic setting is viable and allows optimal clinical care of patients with NMI TSC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberous SclerosisPhenotypeTuberous Sclerosis Complex 2 ProteinTuberous Sclerosis Complex 1 ProteinHumansFemaleMaleAustraliaChildAdolescentAdultChild, PreschoolHigh-Throughput Nucleotide SequencingInfantMutationMosaicism

Stichwörter der Autor:innen

deep sequencinggenotype/phenotype comparisonmosaicismtuberous sclerosis complex

Substanzen

Tuberous Sclerosis Complex 2 ProteinTSC2 protein, humanTuberous Sclerosis Complex 1 ProteinTSC1 protein, human

Autor:innen und Institutionen

  • Centre for Clinical Genetics, Sydney Children's Hospital, Randwick, New South Wales, Australia.
  • Tuberous Sclerosis Management Clinic, Sydney Children's Hospital, Randwick, New South Wales, Australia.
  • Discipline of Paediatrics and Child Health, School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, New South Wales, Australia.
  • Kids Neuroscience Centre, Kids Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia.
  • The Children's Medical Research Institute, Westmead, New South Wales, Australia.
  • Specialty of Child and Adolescent Health, Sydney Medical School, University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Clara W T Chung

Zitieren

APA

Chung, C. W. T., Bournazos, A. M., Chan, L. C. D., Sarkozy, V., Lawson, J., Kennedy, S. E., Cooper, S. T., Kirk, E. P., & Mowat, D. (2024). Deep Sequencing and Phenotyping in an Australian Tuberous Sclerosis Complex “No Mutations Identified” Cohort. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70017

Vancouver

Chung CWT, Bournazos AM, Chan LCD, Sarkozy V, Lawson J, Kennedy SE, et al. Deep Sequencing and Phenotyping in an Australian Tuberous Sclerosis Complex “No Mutations Identified” Cohort. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.70017

BibTeX
@article{Chung2024,
  author = {Chung, Clara W T and Bournazos, Adam M and Chan, Lok Chi Denise and Sarkozy, Vanessa and Lawson, John and Kennedy, Sean E and Cooper, Sandra T and Kirk, Edwin P and Mowat, David},
  title = {Deep Sequencing and Phenotyping in an Australian Tuberous Sclerosis Complex “No Mutations Identified” Cohort},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.70017}
}
Kostenlos starten →